USNA
USANA Health Sciences, Inc.
Set alert
- YTD
- -27.10%
- 1 year
- -27.51%
- Open
- 14.27
- Prev close
- 14.34
- Mkt cap
- 264.40M
- Vol
- 141.02K
- Avg vol
- 209.85K
- EPS
- -1.20
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 14.18
- High
- 14.45
- Forward P/E
- 13.69
- Beta
- 0.89
- Short ratio
- 5.95
- Inst. own
- 57.64%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 4, 2025
- 50-d avg
- 37.85
- 200-d avg
- 42.19
- 1y target
- 46.50
Key statistics
- Market cap
- 646.88M
- Enterprise value
- 271.32M
- Trailing P/E
- 11.99
- Forward P/E
- 13.69
- PEG ratio
- 0.00
- Price / sales
- 0.75
- Price / book
- 1.21
- EPS (TTM)
- 2.83
- Beta
- 0.89
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 6.30%
- Revenue (TTM)
- 861.97M
- Revenue growth
- -6.20%
- Free cash flow
- 71.15M
- Total cash
- 364.89M
- Total debt
- 0
- Return on equity
- 10.83%
- Shares outstanding
- 19.06M
- Short % of float
- 4.42%
- 50-day average
- 37.85
- 200-day average
- 42.19
Analyst view
Consensus: none
- Target (low)
- 35.00
- Target (mean)
- 46.50
- Target (high)
- 58.00
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Feb 4, 2025
Expected Feb 4, 2025. Consensus EPS estimate 0.49.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 4, 2025 | Dec 1, 2024 | 0.49 | — | — | — |
| Oct 22, 2024 | Sep 1, 2024 | 0.49 | 0.56 | +0.07 | +14.29% |
| Jul 23, 2024 | Jun 1, 2024 | 0.65 | 0.54 | -0.11 | -16.92% |
| Apr 30, 2024 | Mar 1, 2024 | 0.69 | 0.86 | +0.17 | +24.64% |
| Feb 6, 2024 | Dec 1, 2023 | 0.52 | 0.87 | +0.35 | +67.31% |
| Oct 24, 2023 | Sep 1, 2023 | 0.64 | 0.59 | -0.05 | -7.81% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 23, 2024 | DA Davidson | main | Neutral | Neutral |
| Jul 25, 2024 | DA Davidson | main | Neutral | Neutral |
| May 7, 2024 | DA Davidson | main | Neutral | Neutral |
| Feb 22, 2024 | DA Davidson | main | Neutral | Neutral |
| Oct 25, 2023 | DA Davidson | main | Neutral | Neutral |
| Apr 26, 2023 | DA Davidson | main | — | Neutral |
About USANA Health Sciences, Inc.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Country
- United States
- Website
- usana.com
News
- USANA Schedules Third Quarter 2026 Earnings Release and Conference Call
- USANA Health Sciences and University of Utah Athletics Announce New Partnership
- USANA CEO Kevin Guest Shares Three Ways to Celebrate International Music Day
- Implied Volatility Surging for USANA Health Stock Options
- Protein Pop Launches Protein Pop Balance, a Clear Prebiotic Soda with 15 Grams of Protein and 5 Grams of Fiber
- USANA CEO Kevin Guest Calls on People to Find a Way to Serve Others, Then Act
- 12 Consumer Staples Stocks Moving In Thursday's After-Market Session
- USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix
- Why Usana Health Sciences Stock Plummeted This Week
- USANA Health Sciences Q2 Earnings Call Highlights
Your note
Sign in to keep a note on USNA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROWN JIM H | Chief Executive Officer | Conversion of Exercise of derivative security | Jul 23, 2024 | 8,707 |
| DING XIA | Director | Conversion of Exercise of derivative security | Oct 31, 2024 | 3,534 |
| FLEMING JOHN TURMAN | Director | Conversion of Exercise of derivative security | Oct 31, 2024 | 3,852 |
| FULLER GILBERT A | Director | Sale | Nov 3, 2024 | 0 |
| JONES PAUL A | Officer | Sale | Aug 12, 2024 | 0 |
| NIXON J SCOTT | Director | Conversion of Exercise of derivative security | Oct 31, 2024 | 4,235 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.50% | 1,809,932 | 61.43M | Sep 29, 2024 |
| Vanguard Group Inc | 8.41% | 1,602,485 | 54.39M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 6.03% | 1,149,264 | 39.01M | Sep 29, 2024 |
| Pzena Investment Management Llc | 5.51% | 1,049,610 | 35.62M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 3.77% | 718,169 | 24.37M | Sep 29, 2024 |
| Pacer Advisors, Inc. | 2.86% | 544,256 | 18.47M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Core S&P Smallcap ETF | 3.70% | 705,335 | 23.94M | Oct 30, 2024 |
| Pacer Small Cap U.S. Cash Cows 100 ETF | 2.43% | 463,397 | 15.73M | Jul 30, 2024 |
| Vanguard Total Stock Market Index Fund | 1.88% | 358,868 | 12.18M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.52% | 289,321 | 9.82M | Oct 30, 2024 |
| Vanguard Small-Cap Index Fund | 1.50% | 286,497 | 9.72M | Sep 29, 2024 |
| Vanguard Small Cap Value Index Fund | 1.02% | 193,725 | 6.58M | Sep 29, 2024 |